Mirabegron as a treatment for overactive bladder symptoms in men (MIRACLE study): Efficacy and safety results from a multicenter, randomized, double-blind, placebo-controlled, parallel comparison phase IV study.
Dong Gil ShinHyeon Woo KimSang Jin YoonSang Hoon SongYoung Ho KimYoung Goo LeeKwan Joong JooJae Hyun BaeTaek Won KangSeong Jin JeongSeung Hyo WooEun Sang YooHwancheol SonKyo Chul KooSoo Woong KimPublished in: Neurourology and urodynamics (2018)
A daily 50 mg dose of mirabegron for 12 weeks reduced OAB symptoms in men, and no significant adverse events compared to the placebo group were noted.